The top 6 potential anti-HCC core targets, i.e., EGFR, CASP3, ESR1, MAPK3, ERBB2, and CCND1, were chosen for molecular docking studies, with key active phytochemicals described in Section 2.6. The gene discussed is ERBB2; the disease is hepatocellular carcinoma.